Clinical Trial Update: Safety and Efficacy Study of Altabax Ointment in the Treatment of Secondarily Infected Atopic Dermatitis [Phase 4]

View source ↗

Summary

Phase 4 trial assessing safety and efficacy of Altabax ointment for secondarily infected atopic dermatitis has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• Altabax (retapamulin)

Snippet

Sponsor: Derm Research, PLLC | Conditions: Atopic Dermatitis, Secondary Infection | Phase 4 | Status: COMPLETED | Results posted: 2013-07-04